Point-of-care antithrombotic monitoring in children

Thrombosis Research

Volumn 118, Issue 1, 2006, Pages 113-121

  Newall, Fiona ^a   Bauman, Mary ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

Anticoagulation; International normalised ratio; Paediatric; Point of care monitoring; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; THROMBOPLASTIN; WARFARIN;

ACCURACY; BLEEDING; CALIBRATION; CORRELATION ANALYSIS; DEVICE; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; FREQUENCY ANALYSIS; HOME CARE; HUMAN; INFORMATION RETRIEVAL; INTERMETHOD COMPARISON; LABORATORY TEST; MANAGEMENT; MEDLINE; METHODOLOGY; MONITOR; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PEDIATRICS; POINT OF CARE TESTING; POPULATION SIZE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RELIABILITY; REVIEW; STANDARD; THROMBOEMBOLISM; THROMBOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FIBRINOLYTIC AGENTS; HOME CARE SERVICES; HUMANS; INFANT; POINT-OF-CARE SYSTEMS; SELF CARE; TREATMENT OUTCOME;

EID: 33646459487     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.03.008     Document Type: Review

References (59)

1. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 74 1 (1995) 415-425
2. Andrew M., Paes B., Milner R., Johnston M., Mitchell L., Tollefsen D., et al. Development of the human coagulation system in the full-term infant. Blood 70 1 (1987) 165-172
3. Monagle P., Michelson A., Bovill E., and Andrew M. Antithrombotic therapy in children. Chest 119 (2001) 344S-370S
4. Burken M., and Whyte J. Home international normalised ratio monitoring: where evidence-base medicine is exemplified in the Medicare coverage process. J Thromb Thrombolysis 13 1 (2002) 5-7
5. Douketis J. Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice. Am J Cardiovasc Drugs 1 4 (2001) 245-251
6. van den Besselaar A. Accuracy, precision and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 12 1 (2001) 35-40
7. Tripodi A., Chantarangkul V., and Mannucci P. Near-patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 113 4 (2001) 847-852
8. Zimmerman C. The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders. J Thromb Thrombolysis 9 3 (2000) 187-198
9. Ruzicka K., Kapiotis S., Quehenberger P., Handler S., Hornykewycz S., Michitsch A., et al. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguChek Plus in various clinical settings. Thromb Res 87 (1997) 431-440
10. Anderson D., Harrison L., and Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulation therapy. Arch Intern Med 153 (1993) 1441-1447
11. Le D., Weibert R., Sevilla B., Donnelly K., and Rapaport S. The international normalized ratio (INR) for monitoring warfarin therapy. Reliability and relation to other monitoring methods. Ann Intern Med 120 (1994) 552-558
12. Andrew M., Ansell J., Becker D., Becker R., and Triplett A. Multi-center trial of accurate home self-testing in oral anticoagulant patients with a novel whole blood system. American society of hematology (1996) 179a
13. Christensen T., Andersen N., Attermann J., Hjortdal V., Maegaard M., and Hasenkam M. Mechanical heart valve patients can manage oral anticoagulant therapy themselves. Eur J Cardio-Thorac Surg 23 (2003) 292-298
14. Christensen T., Attermann J., Hjortdal V., Maegaard M., and JM H. Self-management of oral anticoagulation in children with congenital heart disease. Cardiol Young 11 (2001) 269-276
15. Marzinotto V., Monagle P., Chan A., Adams M., Massicotte P., Leaker M., et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 21 4 (2000) 347-352
16. Massicotte P., Marzinotto V., Vegh P., Adams M., and Andrew M. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr 127 3 (1995) 389-394
17. Nowatzke W., Landt M., Smith C., Wilhite T., Canter C., and Luchtman-Jones L. Whole blood international normalization ratio measurements in children using near-patient monitors. J Pediatr Hematol/Oncol 25 1 (2003) 33-37
18. Lucas F., Duncan A., Jay R., Coleman R., Craft P., Vhan B., et al. A novel whole blood capillary technique for measuring the prothrombin time. Am J Clin Pathol 88 (1987) 442-446
19. Poller L., Keown M., Chauhan N., van den Besselaar A., Meeuwisse-Braun J., Tripodi A., et al. European concerted action on anticoagulation. Use of plasma samples to derive international sensitivity index for whole blood prothrombin time monitors. Clin Chem 48 2 (2002) 255-260
20. Cachia P., McGregor E., Adlakha S., Davey P., and Goudie B. Accuracy and precision of the TAS analyser for near-patient INR testing by non-pathology staff in the community. J Clin Pathol 51 1 (1998) 68-72
21. Gosselin R., Owings J., White R., Hutchinson R., Branch J., Mahackian K., et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost 83 5 (2000) 698-703
22. Kaatz S., White R., Hill J., Mascha E., Humphries J., and Becker D. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med 155 (1995) 1861-1867
23. Kitchen S., and Preston F. Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins. J Clin Pathol 50 11 (1997) 951-956
24. Koerner S., and Fuller R. Comparison of a portable capillary whole blood coagulation monitor and standard laboratory methods for determining international normalized ratio. Mil Med 163 12 (1998) 820-825
25. McCurdy S., and White R. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 152 (1992) 589-592
26. Murray E., Fitzmaurice D., Allan T., and Hobbs F. A primary care evaluation of three near patient coagulometers. J Clin Pathol 52 11 (1999) 842-845
27. Pierce M., Crain L., Smith J., and Mehta V. Point-of-care versus laboratory measurement of the international normalised ratio. Am J Health-Syst Pharm 57 24 (2000) 2271-2274
28. Plesch W., and Klimpel P. Performance evaluation of the CoaguChek S system. Haematologica 87 5 (2002) 557-559
29. Poller L., Keown M., Chauhan N., van den Besselaar A., Tripodi A., Jespersen J., et al. European concerted action on Anticoagulation. Minimum numbers of lyophilized plasma samples for ISI calibration of CoaguChek and TAS point-of-care whole blood prothrombin time monitors. Am J Clin Pathol 119 2 (2003) 232-240
30. Poller L., Keown M., Chauhan N., van den Besselaar A., Tripodi A., Jespersen J., et al. European concerted action on Anticoagulation: multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems. Br J Haematol 116 4 (2002) 844-850
31. Poller L., Keown M., Chauhan N., van den Besselaar A., Tripodi A., Shiach C., et al. European concerted action on anticoagulation. Minimum number of centres for reliable international sensitivity index calibration of CoaguChek and TAS point-of-care whole blood monitors. Thromb Res 107 1-2 (2002) 61-66
32. Poller L., Keown M., Chauhan N., van den Besselaar A., Tripodi A., Shiach C., et al. European concerted action on anticoagulation. Evaluation of a methods for international sensitivity index calibration of two point-of-care prothrombin time monitoring systems (CoaguChek Mini and TAS PT-NC) with fresh plasmas based on whole-blood equivalent PT. Clin Chem 48 10 (2002) 1672-1680
33. Poller L., Keown M., Chauhan N., van den Besselaar A., Tripodi A., Shiach C., et al. European concerted action on Anticoagulation: an assessment of a method for ISI calibration of two whole-blood point-of-care PT monitor systems based on lyophilized plasmas using whole blood equivalent PT. J Thromb Haemost 1 4 (2003) 766-772
34. Poller L., Keown M., Chauhan N., van den Besselaar A., Tripodi A., Shiach C., et al. Reliability of international normalized ratios from two point-of-care test systems: comparison with conventional methods. Br J Haematol 327 7405 (2003) 30
35. Poller L., Keown M., Chauhan N., van den Besselaar A., Tripoti A., Shiach C., et al. European concerted action on anticoagulation. Quality assessment of the CoaguChek Mini and TAS PT-NC point-of-care whole-blood prothrombin time monitors. Clin Chem 50 3 (2004) 537-544
36. Poller L., Keown M., Chauhan N., van den Besselaar A., Tripoti A., Shiach C., et al. European concerted action on anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration. Br J Haematol 122 6 (2003) 944-949
37. Reiss R., Haas C., Griffis D., Porter B., and Tara M. Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapies. Pharmacotherapy 22 6 (2002) 677-685
38. Rigelsky J., Choe H., Curtis D., Brosnan M., Mitrovich S., and Streetman D. Accuracy of the avosure PT pro system compared with a hospital laboratory standard. Ann Pharmacother 36 3 (2002) 380-385
39. Shiach C., Campbell B., Poller L., and Chauhan N. Reliability of point-of-care prothrombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testing. Br J Haematol 119 2 (2002) 370-375
40. Sirithunyanont C., Bhuripanyo K., Kangkagate C., Winyarat W., Srichaya P., and Wangtip K. Accuracy of international normalized ratio determined by portable venous-blood coagulation monitor versus a central laboratory. J Med Assos Thail 86 Suppl. 1 (2003) S67-S75
41. Tay M., Tien S., Chua T., Sim L., and Koh T. An evaluation of point-of-care instrument for monitoring anticoagulation level in adult cardiac patients. Singap Med J 43 11 (2002) 557-562
42. Tripodi A., Chantarangkul V., Bressi C., and Mannucci P. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime. Am J Clin Pathol 119 2 (2003) 241-245
43. van den Besselaar A., Meeuwisse-Braun J., Schaefer-van Mansfeld H., van Rijn C., and Witteveen E. A comparison between capillary and venous blood international normalised ratio determinations in a portable prothrombin time device. Blood Coagul Fibrinolysis 11 6 (2000) 559-562
44. Weibert R., and Aldler D. Evaluation of a capillary whole blood prothrombin time measurement system. Clin Pharm 8 (1989) 864-867
45. Tripodi A., Arbini A., Chantarangkul V., Bettega D., and Mannucci P. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio?. Thromb Haemost 70 (1993) 921-924
46. Ansell J., Hirsh J., Dalen J., Bussey H., Anderson D., Poller L., et al. Managing oral anticoagulant therapy. Chest 119 1 (2001) 22S-38S
47. Ansell J. Patient self-testing and patient self-management of oral anticoagulation: is it too late?. Isr Med Assoc J 4 11 (2002) 1035-1036
48. Sunderji R., Fung A., Gin K., Shalausky K., and Carter C. Patient self-management of oral anticoagulation: a review. Can J Cardiol 19 8 (2003) 931-935
49. Bhavnani M., and Shiach C. Patient self-management of oral anticoagulation. Clin Lab Haematol 24 4 (2002) 253-257
50. Samsa G., and Matchar D. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomised trials of patient self-management. J Thromb Thrombolysis 9 3 (2000) 283-292
51. McCahon D., Fitzmaurice D., Murray E., Fuller C., Hobbs R., Allan T., et al. SMART: self management of anticoagulation, a randomised trial. BMC Fam Pract 4 11 (2003)
52. Sawicki P. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 281 2 (1999) 145-150
53. Andrew M., Monagle P., and Brooker L. Thromboembolic complications during infancy and childhood (2000), BC Decker, Hamilton
54. Massicotte P., Leaker M., Marzinotto V., Adams M., Freedom R., Williams W., et al. Enhanced thrombin regulation during warfarin therapy in children compared to adults. Thromb Haemost 80 4 (1998) 570-574
55. Andrew M., Marzinotto V., Brooker L., Adams M., Ginsberg J., Freedom R., et al. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 71 3 (1994) 265-269
56. Wyness M. Warfarin patient education: are we neglecting the program design process?. Patient Educ Couns 14 (1989) 159-169
57. Hawe P., Degeling D., and Hall J. Evaluating health promotion: a health worker's guide (1992), MacLennan and Petty, Sydney
58. Edelman C., and Mandle C. Health promotion throughout the lifespan. 3rd ed. (1994), Mosby, St. Louis
59. Mor M., and Waisman Y. Point-of-care testing: a critical review. Pediatr Emerg Care 16 1 (2000) 45-48